EP 1257583 A2 20021120 - METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
Title (en)
METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
Title (de)
VERFAHREN ZUR VERHINDERUNG UND BEHANDLUNG VON INFEKTIONEN DURCH DIE VERWENDUNG VON ANTI-C3B(I) ANTIKÖRPERN
Title (fr)
PROCEDES DESTINES A LA PREVENTION ET AU TRAITEMENT D'INFETIONS AU MOYEN D'ANTICORPS ANTI-C3B(I)
Publication
Application
Priority
- US 0104020 W 20010208
- US 18114300 P 20000208
- US 72462100 A 20001128
Abstract (en)
[origin: WO0158483A2] The present invention relates to the treatment and prevention of viral infections, microbial infections, and septic shock by the administration of anti-C3b(i) antibodies. The present invention also relates to methods of treating and preventing viral infection, microbial infection, or septic shock in an animal comprising administering to said animal IgG antibodies, IgM antibodies and/or complement components in combination with antibodies immunospecific for C3b(i). The present invention also relates methods of treating and preventing viral infection or microbial infection in an animal comprising administrating said animal antibodies that immunospecifically bind to one or more viral antigens or microbial antigens, respectively, in combination with antibodies immunospecific for C3b(i). The present invention further relates methods of treating and preventing septic shock in an animal comprising administrating said animal antibodies that immunospecifically bind to lipopolysaccharide, an endotoxin or a constituent of the outer wall of a gram negative bacteria in combination with antibodies immunospecific for C3b(i).
IPC 1-7
C07K 16/18; C07K 16/12; A61K 39/395; A61K 38/17; A61K 31/7088; A61K 39/42; A61K 39/40; A61K 35/16; A61K 47/48; A61K 31/00
IPC 8 full level
A61K 35/12 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 9/00 (2006.01); A61P 17/02 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/14 (2006.01); A61P 31/16 (2006.01); A61P 31/20 (2006.01); A61P 31/22 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
A61P 9/00 (2017.12); A61P 17/02 (2017.12); A61P 31/00 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 31/14 (2017.12); A61P 31/16 (2017.12); A61P 31/20 (2017.12); A61P 31/22 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); C07K 16/18 (2013.01); C07K 16/2896 (2013.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01)
Citation (search report)
See references of WO 0158483A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0158483 A2 20010816; WO 0158483 A3 20020418; AU 3492501 A 20010820; CA 2400488 A1 20010816; EP 1257583 A2 20021120; JP 2003522159 A 20030722
DOCDB simple family (application)
US 0104020 W 20010208; AU 3492501 A 20010208; CA 2400488 A 20010208; EP 01907104 A 20010208; JP 2001557591 A 20010208